Double Medical forecasts strong first-half profit growth

Double Medical Technology expects net profit between RMB 230 million and RMB 250 million for the first half of 2025, representing a year-over-year increase of 66.37% to 80.84% from RMB 138.244 million.

Adjusted net profit is projected between RMB 210 million and RMB 230 million, an increase of 72.23% to 88.63% from RMB 121.9312 million previously. Basic earnings per share are expected to range from RMB 0.5657 to RMB 0.6148, up from RMB 0.3339.

The growth is attributed to new growth patterns in product lines following centralized procurement, continued product innovation, technical services, and international development strategies.